Response Genetics, Inc. RGDX announced
today that it intends to hire a new Chief Executive Officer before
year end 2011. On July 22, 2011, Kathleen Danenberg stepped down from the
position of CEO and was appointed by the Board of Directors to serve as
Founder and Executive Scientific and Technology Officer of the Company to
focus her attention on RGI's scientific research and development activities.
Denise McNairn, the Company's Vice President, General Counsel and Secretary,
will serve as the Company's CEO on an interim basis while the Company searches
for a permanent successor to Ms. Danenberg.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in